- Home
- OB vs CDTX Comparison
OB vs CDTX Comparison
Compare OB & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OB
- CDTX
- Stock Information
- Founded
- OB 2006
- CDTX 2012
- Country
- OB United States
- CDTX United States
- Employees
- OB N/A
- CDTX N/A
- Industry
- OB Industrial Machinery/Components
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OB Industrials
- CDTX Health Care
- Exchange
- OB Nasdaq
- CDTX Nasdaq
- Market Cap
- OB 294.0M
- CDTX 259.0M
- IPO Year
- OB 2021
- CDTX 2015
- Fundamental
- Price
- OB $3.46
- CDTX $18.63
- Analyst Decision
- OB Buy
- CDTX Strong Buy
- Analyst Count
- OB 5
- CDTX 8
- Target Price
- OB $7.10
- CDTX $38.50
- AVG Volume (30 Days)
- OB 355.4K
- CDTX 92.3K
- Earning Date
- OB 05-09-2025
- CDTX 05-08-2025
- Dividend Yield
- OB N/A
- CDTX N/A
- EPS Growth
- OB N/A
- CDTX N/A
- EPS
- OB N/A
- CDTX N/A
- Revenue
- OB $959,268,000.00
- CDTX $302,000.00
- Revenue This Year
- OB $68.11
- CDTX N/A
- Revenue Next Year
- OB $6.22
- CDTX N/A
- P/E Ratio
- OB N/A
- CDTX N/A
- Revenue Growth
- OB 4.15
- CDTX N/A
- 52 Week Low
- OB $3.00
- CDTX $10.14
- 52 Week High
- OB $7.87
- CDTX $28.42
- Technical
- Relative Strength Index (RSI)
- OB 44.03
- CDTX 39.70
- Support Level
- OB $3.43
- CDTX $19.97
- Resistance Level
- OB $3.59
- CDTX $22.80
- Average True Range (ATR)
- OB 0.23
- CDTX 1.47
- MACD
- OB 0.03
- CDTX -0.21
- Stochastic Oscillator
- OB 50.00
- CDTX 2.90
About OB Outbrain Inc.
Outbrain Inc is a platform powering the open web that matches audiences with personalized content and ads, driving quality engagement. Its platform delivers ads to end-users that appear as links to articles, products, and videos on media partners' sites. It derives revenue from advertisers through user engagement with the ads that it places on media partners' web pages and mobile applications. The company has its geographic presence in Europe, the Middle East, and Africa followed by the USA and others.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.